USE OF ADENOSINE A1 RECEPTOR AGONISTS FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION

摘要

The present invention relates to the use of selective adenosine A1 receptor agonists, in particular the dicyanopyridines of formula (I), for the treatment and/or prophylaxis of glaucoma, normotensive glaucoma and ocular hypertension and/or combinations thereof.